The Pharmaceutical Society of Zambia says it is disappointed that innovation of possible COVID-19 cures is receiving backlash.
The Zambia Medicines Regulatory Authority and the Health Professions Council of Zambia said they have instituted investigations into the alleged selling of a drug called COVID-Z allegedly being manufactured, distributed and sold in Zambia by some health practitioners.
But PSZ President Jerome Kanyika says it is unfortunate that facts by the two regulators have been misrepresented stating that COVID-Z is not for sale but is awaiting clinical trials if approved by the Ministry of Health.
Mr. Kanyika has stated that pharmacists will continue undertaking research on the herbal medicine as he is confident that it will help in fighting COVID-19 symptoms.
Mr. Sinkamba has noted that the Ministry of Health has not been responding positively to trials on herbal medicines that have been discovered locally.
Mr. Sinkamba has accused the Ministry of Health Authorities of working in collaboration with the World Health Organization to frustrate the medications that are being produced in Africa.